Prediction of reclassification at repeat biopsy with [-2]proPSA during active surveillance for low-risk prostate cancer: Prospective longitudinal analysis of a Japanese multicenter study cohort.

被引：0
|
作者：
Sugimoto, Mikio
Hirama, Hiromi
Ito, Kazuto
Shiraishi, Taizo
Kakehi, Yoshiyuki
机构：
[1] Kagawa Univ, Dept Urol, Fac Med, Takamatsu, Kagawa 760, Japan
[2] Gunma Univ, Dept Urol, Fac Med, Gunma, Japan
[3] Mie Univ, Dept Pathol Oncol, Grad Sch Med, Tsu, Mie, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16054
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance
    Lin, Daniel W.
    Crawford, E. David
    Keane, Thomas
    Evans, Brent
    Reid, Julia
    Rajamani, Saradha
    Brown, Krystal
    Gutin, Alexander
    Tward, Jonathan
    Scardino, Peter
    Brawer, Michael
    Stone, Steven
    Cuzick, Jack
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 310.e7 - 310.e13
  • [22] The Brazilian national prospective active surveillance (AS) cohort of patients with low-risk prostate cancer in the public health system: vigiaSUS study protocol
    Jeziel Basso
    Juliana Beust de Lima
    Marina Bessel
    Santiago Alonso Tobar Leitão
    Thais Machado Baptista
    Sergio Roithmann
    Eduardo Franco Carvalhal
    Caio da Silva Schmitt
    Ivan Morzoletto Pedrollo
    Alice Schuch
    Antonio Atalibio Hartmann
    Carmen Liane Neubarth Estivallet
    Guilherme Behrend Silva Ribeiro
    Ricardo Andre Zordan
    Pedro Isaacsson Velho
    BMC Urology, 23
  • [23] The Brazilian national prospective active surveillance (AS) cohort of patients with low-risk prostate cancer in the public health system: vigiaSUS study protocol
    Basso, Jeziel
    de Lima, Juliana Beust
    Bessel, Marina
    Tobar Leitao, Santiago Alonso
    Machado Baptista, Thais
    Roithmann, Sergio
    Franco Carvalhal, Eduardo
    da Silva Schmitt, Caio
    Morzoletto Pedrollo, Ivan
    Schuch, Alice
    Atalibio Hartmann, Antonio
    Neubarth Estivallet, Carmen Liane
    Behrend Silva Ribeiro, Guilherme
    Zordan, Ricardo Andre
    Isaacsson Velho, Pedro
    BMC UROLOGY, 2023, 23 (01)
  • [24] Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS Cohort
    Malaret, Adrian J. Waisman
    Chang, Peter
    Newcomb, Lisa
    Faino, Anna
    Zheng, Yingye
    Zhu, Kehao
    McKenney, Jesse K.
    Brooks, James D.
    Dash, Atreya
    Ellis, William J.
    Filson, Christopher P.
    Gleave, Martin
    Liss, Michael
    Martin, Frances M.
    Morgan, Todd
    Carro, Peter
    Nelson, Peter
    Lin, Daniel W.
    Wagner, Andrew A.
    UROLOGY PRACTICE, 2021, 8 (05) : 576 - 582
  • [25] ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer—results from an international multicenter study
    I Heidegger
    H Klocker
    R Pichler
    A Pircher
    W Prokop
    E Steiner
    C Ladurner
    E Comploj
    A Lunacek
    D Djordjevic
    A Pycha
    E Plas
    W Horninger
    J Bektic
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 271 - 275
  • [26] Clinical and Psychological Predictors of Switching from Active Surveillance to Active Treatment among Men with Low-Risk Prostate Cancer: the PREPARE Prospective Cohort Study
    Taylor, K. L.
    Luta, G.
    Zotou, V
    Hoffman, R. M.
    Lobo, T.
    Davis, K. M.
    Potosky, A. L.
    Aaronson, D.
    Van den Eeden, S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (03) : 357 - 358
  • [27] Whole-gland ablation therapy versus active surveillance for low-risk prostate cancer: a prospective study
    Enikeev, Dmitry
    Taratkin, Mark
    Amosov, Alexander
    Rivas, Juan Gomez
    Podoinitsin, Alexei
    Potoldykova, Natalya
    Karageziyan, Marina
    Glybochko, Petr
    Barret, Eric
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2020, 73 (02) : 127 - 133
  • [28] Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability
    Cooperberg, Matthew R.
    Zheng, Yingye
    Faino, Anna V.
    Newcomb, Lisa F.
    Zhu, Kehao
    Cowan, Janet E.
    Brooks, James D.
    Dash, Atreya
    Gleave, Martin E.
    Martin, Frances
    Morgan, Todd M.
    Nelson, Peter S.
    Thompson, Ian M.
    Wagner, Andrew A.
    Carroll, Peter R.
    Lin, Daniel W.
    JAMA ONCOLOGY, 2020, 6 (10)
  • [29] Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance
    Tomer, Anirudh
    Nieboer, Daan
    Roobol, Monique J.
    Bjartell, Anders
    Steyerberg, Ewout W.
    Rizopoulos, Dimitris
    BJU INTERNATIONAL, 2021, 127 (01) : 96 - 107
  • [30] ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter study
    Heidegger, I.
    Klocker, H.
    Pichler, R.
    Pircher, A.
    Prokop, W.
    Steiner, E.
    Ladurner, C.
    Comploj, E.
    Lunacek, A.
    Djordjevic, D.
    Pycha, A.
    Plas, E.
    Horninger, W.
    Bektic, J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (03) : 271 - 275
12345